HDL in Morbidity and Mortality: A 40+ Year Perspective.
作者信息
Tall Alan R
机构信息
Division of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York City, NY.
出版信息
Clin Chem. 2021 Jan 8;67(1):19-23. doi: 10.1093/clinchem/hvaa148.
Abstract
摘要
相似文献
1
HDL in Morbidity and Mortality: A 40+ Year Perspective.
Clin Chem. 2021 Jan 8;67(1):19-23. doi: 10.1093/clinchem/hvaa148.
2
Common variation in genes involved in HDL metabolism influences coronary heart disease risk at the population level.
Rev Endocr Metab Disord. 2004 Dec;5(4):343-9. doi: 10.1023/B:REMD.0000045106.90301.26.
3
TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis.
Nature. 2016 Jul 14;535(7611):303-7. doi: 10.1038/nature18628. Epub 2016 Jul 6.
4
Atherosclerosis Regression and Cholesterol Efflux in Hypertriglyceridemic Mice.
Circ Res. 2021 Mar 19;128(6):690-705. doi: 10.1161/CIRCRESAHA.120.317458. Epub 2021 Feb 3.
5
Single nucleotide polymorphisms in CETP, SLC46A1, SLC19A1, CD36, BCMO1, APOA5, and ABCA1 are significant predictors of plasma HDL in healthy adults.
Lipids Health Dis. 2013 May 8;12:66. doi: 10.1186/1476-511X-12-66.
6
Low-Density Lipoproteins, High-Density Lipoproteins (HDL), and HDL-Associated Proteins Differentially Modulate Chronic Myelogenous Leukemia Cell Viability.
Lipids. 2020 Nov;55(6):615-626. doi: 10.1002/lipd.12254. Epub 2020 Jun 19.
7
microRNAs and HDL life cycle.
Cardiovasc Res. 2014 Aug 1;103(3):414-22. doi: 10.1093/cvr/cvu140. Epub 2014 Jun 3.
8
High-density lipoprotein synthesis and metabolism (Review).
Mol Med Rep. 2015 Sep;12(3):4015-4021. doi: 10.3892/mmr.2015.3930. Epub 2015 Jun 15.
9
HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
Circ Res. 2015 Mar 27;116(7):1133-42. doi: 10.1161/CIRCRESAHA.116.305485. Epub 2015 Jan 14.
10
Gene linked to faulty cholesterol transport.
Science. 1999 Aug 6;285(5429):814-5. doi: 10.1126/science.285.5429.814.
引用本文的文献
1
Modelling the direct and indirect associations between anthropometric and behavioural factors when predicting atherogenic risk index (TC/HDL-C) ratio.
Int J Obes (Lond). 2025 Jul 5. doi: 10.1038/s41366-025-01835-0.
2
Competitive displacement of lipoprotein lipase from heparan sulfate is orchestrated by a disordered acidic cluster in GPIHBP1.
J Lipid Res. 2025 Feb;66(2):100745. doi: 10.1016/j.jlr.2025.100745. Epub 2025 Jan 13.
3
Distinct roles of size-defined HDL subpopulations in cardiovascular disease.
Curr Opin Lipidol. 2025 Jun 1;36(3):111-118. doi: 10.1097/MOL.0000000000000959. Epub 2024 Oct 25.
4
The Comparative Study of Serum Estrogen and Lipid Profile in Pre- and Post-menopausal Women as Atherosclerosis Risk Factors in Pakistan.
Cureus. 2024 Jul 28;16(7):e65604. doi: 10.7759/cureus.65604. eCollection 2024 Jul.
5
Quantification of high-density lipoprotein particle number by proton nuclear magnetic resonance: don't believe the numbers.
Curr Opin Lipidol. 2024 Oct 1;35(5):228-233. doi: 10.1097/MOL.0000000000000948. Epub 2024 Aug 19.
6
Lutein and Zeaxanthin Enhance, Whereas Oxidation, Fructosylation, and Low pH Damage High-Density Lipoprotein Biological Functionality.
Antioxidants (Basel). 2024 May 18;13(5):616. doi: 10.3390/antiox13050616.
7
Secreted dengue virus NS1 from infection is predominantly dimeric and in complex with high-density lipoprotein.
Elife. 2024 May 24;12:RP90762. doi: 10.7554/eLife.90762.
8
Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies?
Diabetologia. 2024 Jun;67(6):974-984. doi: 10.1007/s00125-024-06100-z. Epub 2024 Feb 20.
9
High-Density Lipoproteins at the Interface between the NLRP3 Inflammasome and Myocardial Infarction.
Int J Mol Sci. 2024 Jan 20;25(2):1290. doi: 10.3390/ijms25021290.
10
Changes of tRNA-Derived Fragments by Alzheimer's Disease in Cerebrospinal Fluid and Blood Serum.
J Alzheimers Dis. 2023;96(3):1285-1304. doi: 10.3233/JAD-230412.
本文引用的文献
1
Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques.
Arterioscler Thromb Vasc Biol. 2019 Dec;39(12):e253-e272. doi: 10.1161/ATVBAHA.119.313253. Epub 2019 Oct 3.
2
HDL and Reverse Cholesterol Transport.
Circ Res. 2019 May 10;124(10):1505-1518. doi: 10.1161/CIRCRESAHA.119.312617.
3
LXR Suppresses Inflammatory Gene Expression and Neutrophil Migration through cis-Repression and Cholesterol Efflux.
Cell Rep. 2018 Dec 26;25(13):3774-3785.e4. doi: 10.1016/j.celrep.2018.11.100.
4
Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque.
Arterioscler Thromb Vasc Biol. 2019 Jan;39(1):89-96. doi: 10.1161/ATVBAHA.118.311366.
5
Apolipoprotein A-I Infusion Therapies for Coronary Disease: Two Outs in the Ninth Inning and Swinging for the Fences.
JAMA Cardiol. 2018 Sep 1;3(9):799-801. doi: 10.1001/jamacardio.2018.2168.
6
Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Circulation. 2018 Aug 28;138(9):898-912. doi: 10.1161/CIRCULATIONAHA.117.032636.
7
Trials and Tribulations of CETP Inhibitors.
Circ Res. 2018 Jan 5;122(1):106-112. doi: 10.1161/CIRCRESAHA.117.311978. Epub 2017 Oct 10.
8
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.
N Engl J Med. 2017 Sep 28;377(13):1217-1227. doi: 10.1056/NEJMoa1706444. Epub 2017 Aug 28.
9
Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes.
JAMA Cardiol. 2016 Sep 1;1(6):692-9. doi: 10.1001/jamacardio.2016.1884.
10
TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis.
Nature. 2016 Jul 14;535(7611):303-7. doi: 10.1038/nature18628. Epub 2016 Jul 6.
Zotero 插件